HCP Media Library
Watch and listen to learn more about colorectal cancer (CRC) screening.
Dr. Fenton Shares His Story of CRC Screening
See how Dr. Fenton screened with Cologuard® and caught CRC early, and how it impacted his approach to CRC screening

Dr. Fenton is a primary care physician at Beth Israel Deaconess Medical Center in Salem, NH. He practices family medicine, where he recommends CRC screening to his eligible patients. After becoming eligible himself, he screened for CRC with Cologuard. The result came back positive, prompting a follow-up with a colonoscopy. The colonoscopy revealed that although his cancer was very close to his lymph nodes, it was stage I and treatable. Dr. Fenton is now cancer-free. Since then, he has a renewed sense of urgency when it comes to regular screening and uses his own story to offer CRC screening to patients.
Dr. Durado Brooks Reviews the Current State of CRC Screening
Watch Dr. Brooks discuss various topics pertaining to CRC and Cologuard
-
Dr. Brooks urges eligible adults to get screened for CRC in order to bring us closer to the National Colorectal Cancer Roundtable screening goal.
-
Dr. Brooks discusses CRC survival rates and how they can be impacted by offering choice.
-
Dr. Brooks introduces the pivotal Cologuard trial, written by Imperiale et al and published in The New England Journal of Medicine in 2014.
-
Dr. Brooks dives into the results of the pivotal Cologuard trial.
-
Dr. Brooks explores the 4 questions doctors need to answer in order to determine whether or not a patient is eligible for Cologuard.

Durado Brooks, MD, MPH, is the Deputy Chief Medical Officer at Exact Sciences.
In this role he serves as liaison for scientifically driven engagements, and contributes to the design, conduct, and reporting of innovative research. Dr. Brooks leads strategic outreach and collaboration, designed to increase cancer screening and improve outcomes in traditionally underserved populations. An internist by training, he has spent much of his career working to enhance the role of prevention in primary care, and to improve care for medically underserved populations. An Ohio native, Dr. Brooks received his medical degree from Wright State University School of Medicine in Dayton, Ohio, where he subsequently completed his internal medicine residency and served as Chief Resident. Additionally, Dr. Brooks holds a Master of Public Health (MPH) degree from the Harvard School of Public Health. Prior to joining Exact Sciences, Dr. Brooks was the Vice President of Prevention and Early Detection for the American Cancer Society. His work involved creating strategies to improve the prevention and early detection of cancer, and to assist those who are diagnosed with the disease.
-
The U.S. Preventive Services Task Force (USPSTF) recommends starting CRC screening for average-risk patients at age 45 (Grade B recommendation) 1*
Listen in to hear about the recent update to the USPSTF CRC screening recommendations for average risk patients, including starting screening at age 45. This video will also provide an overview of the evidence that supports the new screening age and the potential impact of offering choice in CRC screening.
Dr. Paul Limburg, a gastroenterologist with over 20 years of experience in clinical practice and the Chief Medical Officer for Screening at Exact Sciences, shares insights on how this update may impact CRC screening in your practice.
Listen in to hear about the recent update to the USPSTF CRC screening recommendations for average risk patients, including starting screening at age 45. This video will also provide an overview of the evidence that supports the new screening age and the potential impact of offering choice in CRC screening.
Dr. Paul Limburg, a gastroenterologist with over 20 years of experience in clinical practice and the Chief Medical Officer for Screening at Exact Sciences, shares insights on how this update may impact CRC screening in your practice.
-
Exact Sciences Laboratories Virtual Lab Tour
Take this virtual tour for a sneak peek inside Exact Sciences Laboratories in Madison, Wisconsin. Learn how this innovative, customer-focused, mission-driven facility delivers colorectal cancer screening results for patients nationwide with Cologuard. You will see that no matter how far apart we are, patients are still within reach.Take this virtual tour for a sneak peek inside Exact Sciences Laboratories in Madison, Wisconsin. Learn how this innovative, customer-focused, mission-driven facility delivers colorectal cancer screening results for patients nationwide with Cologuard. You will see that no matter how far apart we are, patients are still within reach.